| Model Number |
GWBC30 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Death (1802); Cardiac Perforation (2513)
|
| Date of Event |
10/29/2020
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Product analysis: the product was discarded, therefore no product analysis can be performed.Conclusion: without return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that prior to the implant of a transcatheter bioprosthetic valve, a left ventricle perforation occurred with this guidewire.The patient stabilized and the valve was implanted.The patient was transferred to the operating room, but expired.Per the physician, the cause of death was unknown.It is unknown if an autopsy was performed.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b5 - additional information was received that the guidewire was inspected prior to use for any damage.The guidewire was not manipulated prior to use or torqued/twisted.The guidewire was introduced into the ventricle via pigtail catheter and there was no resistance felt.It was unknown if the patient had friable tissue.Contributing factors to the perforation may have been that the patient was large and imaging was poor making it difficult to visualize.Per the physician, guidewire caused the ventricle perforation.H6- patient codes additional codes - (b)(6) impact codes medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|